BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9539710)

  • 1. Direct evidence for a predominantly exolytic processive mechanism for depolymerization of heparin-like glycosaminoglycans by heparinase I.
    Ernst S; Rhomberg AJ; Biemann K; Sasisekharan R
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4182-7. PubMed ID: 9539710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass spectrometric and capillary electrophoretic investigation of the enzymatic degradation of heparin-like glycosaminoglycans.
    Rhomberg AJ; Ernst S; Sasisekharan R; Biemann K
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4176-81. PubMed ID: 9539709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometric evidence for the enzymatic mechanism of the depolymerization of heparin-like glycosaminoglycans by heparinase II.
    Rhomberg AJ; Shriver Z; Biemann K; Sasisekharan R
    Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12232-7. PubMed ID: 9770469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequencing complex polysaccharides.
    Venkataraman G; Shriver Z; Raman R; Sasisekharan R
    Science; 1999 Oct; 286(5439):537-42. PubMed ID: 10521350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncovering the detailed mode of cleavage of heparinase I toward structurally defined heparin oligosaccharides.
    Zhang C; Tang F; Zhang J; Cao J; Li H; Liu C
    Int J Biol Macromol; 2019 Dec; 141():756-764. PubMed ID: 31479666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin.
    Shriver Z; Sundaram M; Venkataraman G; Fareed J; Linhardt R; Biemann K; Sasisekharan R
    Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10365-70. PubMed ID: 10984532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of the substrate specificity of heparin and heparan sulfate lyases.
    Linhardt RJ; Turnbull JE; Wang HM; Loganathan D; Gallagher JT
    Biochemistry; 1990 Mar; 29(10):2611-7. PubMed ID: 2334685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparinase I acts on a synthetic heparin pentasaccharide corresponding to the antithrombin III binding site.
    Yu G; LeBrun L; Gunay NS; Hoppensteadt D; Walenga JM; Fareed J; Linhardt RJ
    Thromb Res; 2000 Dec; 100(6):549-56. PubMed ID: 11152935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tandem mass spectrometry of sulfated heparin-like glycosaminoglycan oligosaccharides.
    Zaia J; Costello CE
    Anal Chem; 2003 May; 75(10):2445-55. PubMed ID: 12918989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequencing of 3-O sulfate containing heparin decasaccharides with a partial antithrombin III binding site.
    Shriver Z; Raman R; Venkataraman G; Drummond K; Turnbull J; Toida T; Linhardt R; Biemann K; Sasisekharan R
    Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10359-64. PubMed ID: 10984531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparinase II from Flavobacterium heparinum. Role of histidine residues in enzymatic activity as probed by chemical modification and site-directed mutagenesis.
    Shriver Z; Hu Y; Sasisekharan R
    J Biol Chem; 1998 Apr; 273(17):10160-7. PubMed ID: 9553064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The calcium-binding sites of heparinase I from Flavobacterium heparinum are essential for enzymatic activity.
    Liu D; Shriver Z; Godavarti R; Venkataraman G; Sasisekharan R
    J Biol Chem; 1999 Feb; 274(7):4089-95. PubMed ID: 9933602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparinase 1 selectivity for the 3,6-di-O-sulfo-2-deoxy-2-sulfamido-alpha-D-glucopyranose (1,4) 2-O-sulfo-alpha-L-idopyranosyluronic acid (GlcNS3S6S-IdoA2S) linkages.
    Xiao Z; Zhao W; Yang B; Zhang Z; Guan H; Linhardt RJ
    Glycobiology; 2011 Jan; 21(1):13-22. PubMed ID: 20729345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the structure of oligosaccharides prepared from acharan sulfate.
    Kim YS; Ahn MY; Wu SJ; Kim DH; Toida T; Teesch LM; Park Y; Yu G; Lin J; Linhardt RJ
    Glycobiology; 1998 Sep; 8(9):869-77. PubMed ID: 9675219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomness in the heparin polymer: computer simulations of alternative action patterns of heparin lyase.
    Cohen DM; Linhardt RJ
    Biopolymers; 1990; 30(7-8):733-41. PubMed ID: 2275975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hexasaccharides from the histamine-modified depolymerization of porcine intestinal mucosal heparin.
    Chuang WL; McAllister H; Rabenstein DL
    Carbohydr Res; 2002 May; 337(10):935-45. PubMed ID: 12007476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of heparinase I of Bacteroides stercoris HJ-15 and its degradation tendency toward heparin-like glycosaminoglycans.
    Hyun YJ; Jung IH; Kim DH
    Carbohydr Res; 2012 Oct; 359():37-43. PubMed ID: 22925762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning, expression and characterization of acharan sulfate-degrading heparin lyase II from Bacteroides stercoris HJ-15.
    Hyun YJ; Lee KS; Kim DH
    J Appl Microbiol; 2010 Jan; 108(1):226-35. PubMed ID: 19566715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression in Escherichia coli, purification and characterization of heparinase I from Flavobacterium heparinum.
    Ernst S; Venkataraman G; Winkler S; Godavarti R; Langer R; Cooney CL; Sasisekharan R
    Biochem J; 1996 Apr; 315 ( Pt 2)(Pt 2):589-97. PubMed ID: 8615834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immobilization alters heparin cleaving properties of heparinase I.
    Bhushan I; Alabbas A; Kuberan B; Gupta RB; Desai UR
    Glycobiology; 2017 Nov; 27(11):994-998. PubMed ID: 28973365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.